Journals / Ege Tıp Dergisi / 2010 / Cilt: 49 - Sayı: 1

The importance of serum markers to detect the activity of Sarcoidosis

Sarkoidoz'da aktivite belirlemede serum belirteçlerinin önemi

Pages
41–48
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, our findings suggest that there are correlations between lymphocyte derived markers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aims of the present study were investigating the role of serum markers in estimating disease activity in sarcoidosis and determining the relationships between these markers.
📊
Key Findings & Data:The levels of total ADA, ADA1, ADA2, ACE and IgE were determined in sera.
💡
Conclusion & Impact:However, our findings suggest that there are correlations between lymphocyte derived markers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The aims of the present study were investigating the role of serum markers in estimating disease activity in sarcoidosis and determining the relationships between these markers. Material and Methods: The diagnosis of sarcoidosis was based on the clinical, radiological and hystopathological findings. The disease activity was determined according to the clinical and radiological findings and the results of pulmonary function tests. The levels of total ADA, ADA1, ADA2, ACE and IgE were determined in sera. The patients were divided into two groups according to the disease activity in year 1 and year 2. Results: There were no significant differences regarding mean serum levels of five markers between patients with active and inactive disease course. In patients with active disease course over last one year, there were significant correlations between serum levels of IgE-ADA1 and IgE-total ADA, ADA1-ADA2, and ADA1- total ADA. In patients with inactive disease course over last one year, there were significant correlations between serum levels of ADA1 - total ADA, ADA 2 - total ADA. Conclusion: Our findings suggest that there were no significant correlation between disease activity and serum levels of five markers in patients with sarcoidosis. However, our findings suggest that there are correlations between lymphocyte derived markers.

Özet

Amaç: Sarkoidoz'da hastalığın aktivitesi, klinik takipte, tedavi kararını vermede, bu tedavinin şekli ve süresini belirlemede önemlidir. Çalışmamızda serum belirteçlerin sarkoidozda aktivite kriteri olarak yerini ve bu kriterlerin birbirleri ile olan ilişkilerini araştırmayı amaçladık. Gereç Yöntem: Birinci yıl için 77, ikinci yıl için 57 sarkoidoz tanılı olguları çalışmaya aldık. Hastaların klinik, radyolojik ve pulmoner fonksiyon olarak aktivite ve inaktivite tanımlanması yapıldı. Serumdan total ADA, ADA1, ADA 2, ACE ve IgE ölçümü yapıldı. Hastalar 1. yıl için aktif ve inaktif olanlar ve 2. yıl için aktif ve inaktif olanlar olmak üzere iki gruba ayrıldı. Bulgular: Aktif ve inaktif olan olguların yaş ortalamaları, cinsiyet dağılımları arasında istatistiksel olarak anlamlı bir farklılık bulunmadı. Son bir yıldır ve son 2 yıldır aktif veya inaktif olguların ACE, IgE, ADA 1, ADA 2 ve total ADA ortalamaları arasında istatistiksel olarak anlamlı bir farklılık bulunmadı. Son 1 yıldır aktif olan olguların serum belirteçleri dikkate alındığında IgE -ADA 1, IgE - total ADA arası, ADA 1-ADA 2, ADA 1-total ADA, inaktif olan olgular dikkate alındığında ADA 1-total ADA, ADA 2-total ADA değerleri arasında anlamlı korelasyon bulundu. Sonuç: Aktif ve inaktif sarkoidozlu hastaları karşılaştırdığımızda bu beş belirteç açısından anlamlı bir fark saptamadık. Fakat lenfosit kaynaklı belirteçler (Total ADA, ADA1, ADA2, IgE) arasında anlamlı korelasyon saptadık.

🔖

Cite This Article

ARSLAN, S. O., ÇELİK, O. T., BARAN, S. A., GÜNGÖR, D. S., AKKAYA, E. (2010). The importance of serum markers to detect the activity of Sarcoidosis. Ege Tıp Dergisi, Cilt: 49 - Sayı: 1, 41–48. https://ajindex.com/articles/222841

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Consensus conference: Activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. Eur Respir J 1994; 7:624-627 2) Çağatay T, Bilir S, Yanardağ H, Gulbaran Z, Papila C. Pulmoner sarkoidozlu olgularda immunglobulin ve kompleman düzeylerinin hastalığın aktivasyonuyla ilişkisi. Solunum Hastalıkları 1999; 10: 254–258. 3) Planck A, Eklund A, Grunewald J. Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients. Eur Respir J 2003; 21: 52-57 4) Rothkrantz-Kos S, Dieijen-Vesser MP, Mulder PGH, Drent M. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clinical Chemistry 2003; 49: 1510-1517 5) ATS/ERS/WASOG Committee. Statement on Sarcoidosis. Am J Crit Care Med 1999; 160:73755 6) Costabel Ulrich, Hunninghake Gary. W. (on behalf of the sarcoidsis statment comitte).ATS/ERS/WASOG statment on sarcoidosis. Eur respir J 1999;14:735-737 7) Rust M, Bergman L, Kuhn T et al. Prognostic value of chest radiograph, serum ACE, T hepler cell count in blood and in bronchoalveolar lavage of patients with pulmonary sarcoidosis. Respiration 1985; 48: 231-236. 8) Morell F, Levy G, Orriols R et al. Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosis. Chest 2002; 121; 1239-1244. 9) Lawrwnce EC, Brousseau KP, Berger MB et al. Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis. Am Rev Resp Dis 1988, 137; 759-764. 10) Ogushi F, Sone S, Singh SM et al. Elevated level of soluble interleukin-2 receptor in bronchoalveolar lavage fluid from sarcoidosis patients. Jpn J Med. 1991 Mar-Apr;30(2):113-117. 11) Eklund A, Blaschke E. Elevated serum neopterin levels in sarcoidosis. Lung 1986;164; 325-332 12) Papadopoulos KI, Melander O, Orho-Melander M, Groop LC et al. Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases. J Intern Med. 2000 Jan; 247:71-77 13) Quernheim -Müller J. Sarcoidosis: Clinical manifestations, staging and therapy (part 2). RespirMed 1998; 92: 140-149. 14) Liebermann J, Schleissner LA, Nosal A. et al. Clinical correlation of serum ACE in sarcoidosis; A longitutinal study of serum ACE, Ga67 scan, chest roentgenograms and pulmonary function. Chest 1983; 84; 522-528. 15) Baughman RP, Fernandez M, Bosken CH, Mantil J, Hurtubise P. Comparison of galiium 67 scanning, bronchoa